Scholarlink

Introduction <p>Glaucoma is a leading cause of irreversible blindness worldwide, with profound physical and psychosocial effects. In Ethiopia, limited access to specialized eye care, delayed diagnosis, and low awareness exacerbate its impact on patients’ quality of life. This review aimed to synthesize existing evidence on the prevalence and determinants of poor QoL among glaucoma patients in Ethiopia.</p> Methods <p>Following the PRISMA 2020 guidelines, a systematic search was conducted across PubMed, Scopus, Web of Science, CINAHL, and Google Scholar up to March 2025 (PROSPERO: CRD420251018342). Eligible studies assessed QoL among adult glaucoma patients in Ethiopia using standardized instruments. Methodological quality was appraised using the Joanna Briggs Institute checklist, and a random-effects model was applied to estimate pooled prevalence. Heterogeneity was evaluated with I<sup>2</sup> statistics, and certainty of evidence was assessed using the GRADE framework.</p> Results <p>Four hospital-based studies met the inclusion criteria. Three NEI-VFQ-25 studies were meta-analyzed, yielding a pooled prevalence of 47% (95% CI: 44–50; I<sup>2</sup> = 19.6%). One additional WHOQOL-BREF study, which was not pooled because of tool heterogeneity, reported a comparable prevalence of 46.3%. Factors consistently associated with poorer QoL included older age, rural residence, low education, economic hardship, limited healthcare access, disease severity, and psychological distress.</p> Conclusion and recommendations <p>Nearly half of Ethiopian glaucoma patients experience impaired QoL. The certainty of this evidence is low to very low due to cross-sectional study designs and limited representativeness. Strengthening early detection, equitable access to eye care, patient education, and psychosocial support is essential, while community-based longitudinal studies are needed to generate higher-quality evidence.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of glaucoma on quality of life: a systematic review and meta-analysis in Ethiopia

  • 期刊论文

  • 发表日期：

    2026年3月31日

查看全文
  • Sadik Abdulwehab,
  • Kumale Tolesa,
  • Frezer Kedir

摘要

Introduction

Glaucoma is a leading cause of irreversible blindness worldwide, with profound physical and psychosocial effects. In Ethiopia, limited access to specialized eye care, delayed diagnosis, and low awareness exacerbate its impact on patients’ quality of life. This review aimed to synthesize existing evidence on the prevalence and determinants of poor QoL among glaucoma patients in Ethiopia.

Methods

Following the PRISMA 2020 guidelines, a systematic search was conducted across PubMed, Scopus, Web of Science, CINAHL, and Google Scholar up to March 2025 (PROSPERO: CRD420251018342). Eligible studies assessed QoL among adult glaucoma patients in Ethiopia using standardized instruments. Methodological quality was appraised using the Joanna Briggs Institute checklist, and a random-effects model was applied to estimate pooled prevalence. Heterogeneity was evaluated with I2 statistics, and certainty of evidence was assessed using the GRADE framework.

Results

Four hospital-based studies met the inclusion criteria. Three NEI-VFQ-25 studies were meta-analyzed, yielding a pooled prevalence of 47% (95% CI: 44–50; I2 = 19.6%). One additional WHOQOL-BREF study, which was not pooled because of tool heterogeneity, reported a comparable prevalence of 46.3%. Factors consistently associated with poorer QoL included older age, rural residence, low education, economic hardship, limited healthcare access, disease severity, and psychological distress.

Conclusion and recommendations

Nearly half of Ethiopian glaucoma patients experience impaired QoL. The certainty of this evidence is low to very low due to cross-sectional study designs and limited representativeness. Strengthening early detection, equitable access to eye care, patient education, and psychosocial support is essential, while community-based longitudinal studies are needed to generate higher-quality evidence.